Successful gene transfer into specific renal structures allows for eva
luation of in vivo effects of certain molecules on the structure and f
unction of the kidney. It would also be useful for therapeutic interve
ntion in renal diseases by introducing ''beneficial'' genes into the a
ffected sites. Towards achieving these goals, several gene transfer ap
proaches have been developed using retrovirus, adenovirus and liposome
. By introducing these gene transfer vectors via particular access rou
tes, it is feasible to selectively manipulate the function of certain
renal structures. Through the renal circulation, exogenous genes can b
e targeted to the vasculature and glomerulus, and possibly to the prox
imal rubles. Using a retrograde approach via the urinary tract, access
to the collecting ducts can be gained. Implantation of genetically mo
dified cells under the capsule of the kidney allows for diffusion of t
ransgene products into the interstitium. Transplantation of embryonic
metanephric tissues also provides a biological window for genetic mani
pulation. Furthermore, utilisation of fertilised eggs or embryonic ste
m cells would enable the creation of ''transgenic kidneys'' or ''gene
knockout kidneys''. This article summarises the current experience wit
h gene transfer to the kidney and addresses the potential strategies i
n vivo.